Azelastine
Back to searchMolecule Structure
Scientific Name
Azelastine
Description of the Drug
Azelastine is a histamine H1-receptor antagonist used intranasally to treat allergic and vasomotor rhinitis and in an ophthalmic solution to treat allergic conjunctivitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00972
http://www.drugbank.ca/drugs/DB00972
Brand Name(s)
Not Available
Company Owner(s)
Alkem Laboratories Ltd, Amneal Pharmaceuticals Llc, Zydus Pharmaceuticals Usa Inc, Meda Pharmaceuticals Inc, Akorn Operating Co Llc, Mylan Specialty Lp A Viatris Co, Apotex Inc Richmond Hill, Upsher Smith Laboratories Llc, Aurobindo Pharma Ltd, Somerset Therapeutics Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4239 | |||
PharmGKB | PA448517 | |||
Human Metabolome Database | HMDB0015107 | |||
DrugBank | DB00972 | |||
PubChem: Thomson Pharma | 14829436 | |||
PubChem | 2267 | |||
LINCS | LSM-5127 | |||
Nikkaji | J13.831B | |||
BindingDB | 50341448 | |||
EPA CompTox Dashboard | DTXSID6022638 | |||
DrugCentral | 271 | |||
ChemicalBook | CB6256007 | |||
Guide to Pharmacology | 7121 | |||
rxnorm | AZELASTINE | AZELASTINE HYDROCHLORIDE | ASTEPRO | ASTELIN |
KEGG Ligand | C07768 | |||
ChEBI | 2950 |